CC BY 4.0 · Rev Bras Ginecol Obstet 2022; 44(11): 1079-1080
DOI: 10.1055/s-0042-1757970
Reply to the Letter to the Editor

Authors' reply

1   Coordenação Geral do Programa Nacional de Imunizações, Ministério da Saúde, Brasília, DF, Brazil
,
1   Coordenação Geral do Programa Nacional de Imunizações, Ministério da Saúde, Brasília, DF, Brazil
,
1   Coordenação Geral do Programa Nacional de Imunizações, Ministério da Saúde, Brasília, DF, Brazil
,
1   Coordenação Geral do Programa Nacional de Imunizações, Ministério da Saúde, Brasília, DF, Brazil
,
1   Coordenação Geral do Programa Nacional de Imunizações, Ministério da Saúde, Brasília, DF, Brazil
,
2   Centro Universitário Faculdade de Medicina do ABC, Santo André, SP, Brazil
› Author Affiliations
 

Adverse Events Related to COVID-19 Vaccines in Pregnant Women: Correspondence

Spontaneous abortion is the most frequent adverse outcome in pregnancy, with a rate of 10% to 20% of all pregnancies. In Brazil, the rate of abortion before the COVID-19 pandemic was of 3.5%. In our study, we observed 24 miscarriages after 678,025 doses of COVID-19 vaccines had been administered in pregnant women in Brazil, which corresponds to an incidence of 3.5 cases per 100,000 doses.[1] Such incidence is lower than the postvaccination rate of abortion related to COVID-19 vaccines described by Trostle et al.[2] and much lower than the historical 3.5% expected rate in Brazil.

Our study was observational and used passive surveillance data. Such studies cannot describe the exact rates of abortion in vaccinated pregnant women. Nonetheless, given the historical rates in Brazil, the expected number of abortions in 678,025 normal pregnancies would be 23,731, which averages out to 616 abortions per week of observation. Even if we consider reporting rates lower than 5%, our incidence of abortions would still be far below the expected.[3]

Currently, the Brazilian Ministry of Health and the Pan American Health Organization (PAHO) are conducting a prospective active surveillance study with women who were vaccinated against COVID-19 during pregnancy in the 5 regions of the country. Such study will enable a more accurate description of the true rates of abortion and other adverse pregnancy outcomes in vaccinated women.

It is already known that pregnant women have a higher risk of developing severe COVID-19 and an increased risk of having adverse maternal and neonatal outcomes after COVID-19. We believe that our data, in association with the previously-published literature, suggests that the benefits of vaccinating pregnant women against COVID-19 far outweighs the risk of the disease.[4]


#

Conflict of Interests

The authors have no conflict of interests to declare.

  • References

  • 1 Kim C, Barnard S, Neilson JP, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev 2017; 1 (01) CD007223 Doi: 10.1002/14651858.CD007223.pub4
  • 2 Trostle ME, Limaye MA, Avtushka V, Lighter JL, Penfield CA, Roman AS. COVID-19 vaccination in pregnancy: early experience from a single institution. Am J Obstet Gynecol MFM 2021; 3 (06) 100464 Doi: 10.1016/j.ajogmf.2021.100464
  • 3 Sookaromdee P, Wiwanitkit V. Magnitude of abortion after COVID-19 vaccination: how about rate?. Erciyes Med J 2022; 44 (02) 244 Doi: 10.14744/etd.2021.78379
  • 4 Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L. et al; CDC v-safe COVID-19 Pregnancy Registry Team. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med 2021; 384 (24) 2273-2282 Doi: 10.1056/NEJMoa2104983

Address for correspondence

Carla Dinamerica Kobayashi
SRTVN
Quadra 701, Bloco D, Ed. PO 700, 6° andar-CGPNI, 70719-040, Brasília, DF
Brazil   

Publication History

Article published online:
29 December 2022

© 2022. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical Publishers
333 Seventh Avenue, New York, NY 10001, USA.

  • References

  • 1 Kim C, Barnard S, Neilson JP, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev 2017; 1 (01) CD007223 Doi: 10.1002/14651858.CD007223.pub4
  • 2 Trostle ME, Limaye MA, Avtushka V, Lighter JL, Penfield CA, Roman AS. COVID-19 vaccination in pregnancy: early experience from a single institution. Am J Obstet Gynecol MFM 2021; 3 (06) 100464 Doi: 10.1016/j.ajogmf.2021.100464
  • 3 Sookaromdee P, Wiwanitkit V. Magnitude of abortion after COVID-19 vaccination: how about rate?. Erciyes Med J 2022; 44 (02) 244 Doi: 10.14744/etd.2021.78379
  • 4 Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L. et al; CDC v-safe COVID-19 Pregnancy Registry Team. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med 2021; 384 (24) 2273-2282 Doi: 10.1056/NEJMoa2104983